“showed a trend”

Trunk:limb ratio showed a trend towards being associated with Hb, yet this did not reach significance ( β = 1.49, p < 0.10).

Antipsychotic treatment showed a trend of a longer duration in serious versus non-serious reactions (22.00 days, quartile 1–3 [Q1–Q3] 12.00–46.00, vs. 16.00 days, Q1–Q3 4.00–23.00, p = 0.10).

maxima infection ( P < 0.05), whereas the ratio of villus height to crypt depth in the jejunum showed a trend of a quadratic effect ( P < 0.1).

Similarly, the PCoA plot based on unweighted UniFrac distances showed a trend toward segregation between PRE and POST samples ( p = 0.1, PERMANOVA), while the weighted UniFrac-based PCoA plot did not ( Supplementary Materials, Figure S2 ).

Alertness enhancement was consistent with EPI elevation, which showed a trend (p < 0.10): Women VIA 135.9±97.9% vs DCF 5.6±29.7%; men VIA 21.0±87.2% vs.

Their analysis showed a trend toward a reduced risk of complications in the antibiotic-treated group [RR (95%CI): 0.43 (0.16, 1.18) p=0.10], without prolonging the length of hospital stay [mean difference (inverse variance, random, 95% CI): 0.11 (-0.22, 0.43) p=0.53].

Good to adequate presurgical Karnofsky performance scores (KPS ≥ 70) showed a trend toward improved OS (mean OS: 109 vs. 68.2 months; p < 0.1), while patients with preradiotherapy KPS ≥ 70 had significantly better OS (median OS: 39.8 months vs. not applicable (NA); p < 0.01).

Cognition as assessed by the EpiTrack tool showed a trend toward improvement, with mean (SD) scores of 27.7 (2.2) at baseline and 29.1 (2.1) at 8-month follow-up visit (mean change +1.30; P < .10).

However, the substitution effect showed a trend ( p < 0.1) for the WBSF and CL variables, indicating an increase in the cutting force (0.313 N) and a decrease in cooking losses (−0.267%) when changing the G allele for A.

Compared to the sows in the LN group, sows fed the LN + YC diet showed a trend for greater activity of serum SOD at 1 d postpartum (174 vs. 195 U/mL, P < 0.10), but there was little evidence of differences in other serum indexes.

In addition, 100% orange juice (OJ) showed a trend (p<0.10) of better performance on cognitive assessment in CC.

LZc showed a trend to correlate with the CRS-R scale ( p = .10), while the PPS measure did not.

In terms of the LAT1 mRNA abundance, the 0.02% group was noticeably richer than the control group, and the 0.04% group showed a trend to intensify its expression (0.05 < P < 0.10).

The association between TP53 mutation and CDKN2A deletion showed a trend towards mutually exclusivity (Fisher’s exact test, P = 0.10).

Patients with the coagulopathic endotype showed a trend toward higher mortality compared to those with the adaptive endotype (34% vs. 18%, odds ratio 2.36, 95% CI 0.87–6.95, p = 0.10; Tables 2 and S10).

Any variables that showed a trend towards significant association with ClinL ( P- value < 0.1) were selected for entry into a multivariable logistic regression.

Additionally, PAH combination therapy (all cases were a combination of a PDE5 inhibitor and an ERA) also showed a trend towards a survival benefit compared with monotherapy alone ( p = 0.10).

Characteristics that achieved significance ( p < 0.05) or showed a trend ( p ≤ 0.10) were included in the prognostic instrument designed to predict the probability of developing new cerebral metastases distant from the lesions treated with radiosurgery.

Variables that reached statistical significance ( p ≤ 0.05) and those that showed a trend towards association with knowledge score ( p ≤ 0.1 was accepted), were included in the multivariate model.

Results Three of the 28 SNPs showed a trend to be associated with T2D in our first case-control set (P < 0.10).

In addition, the total areas of GFP positive blood cell occlusions in the capillaries showed a trend (0.05< p <0.1) towards decreasing in the SCF+G-CSF-treated TgNotch3R90C mice ( p =0.06) ( Fig. 4C ).

As a result, the threshold for anger in Cases B and C showed a trend for being higher than in the control group ( t = 1.46, p < 0.10; Table 1 ).

AFR ancestry was associated with a higher CHD risk after adjusting for age (HR 2.91, p = 0.03), but it only showed a trend in in the fully adjusted model (HR 2.46, p = 0.10).

At that time point, metabolic responders according to the RR dichotomization showed a trend for longer survival according to the conventional PET criteria (EORTC, PERCIST; p < 0.1), which, moreover, was statistically significant with the immunotherapy-modified PERCIMT and imPERCIST5 ( p < 0.05).

Statistically, this difference was not significant on the 5% level but showed a trend with p < .1.